Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study

87

Citations

10

References

2017

Year

G Schmieder, Zoé Kececioglu Draelos, David M. Pariser, Christopher Banfield, Lori Ann Cox, Martin R. Hodge, Elizabeth Kieras, Dana Parsons‐Rich, S. Menon, M.P. Salganik,

British Journal of Dermatology

Abstract

These results suggest that treatment with PF-04965842 improves symptoms and is well tolerated in patients with moderate-to-severe psoriasis.

References

	Year	Citations

Page 1